Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Testing for HER2 status.

W Hanna1

  • 1Sunnybrook and Women's College Health Sciences Centre, Toronto, Ont., Canada. wedad.hanna@swchsc.on.ca

Oncology
|November 6, 2001
PubMed
Summary
This summary is machine-generated.

Accurate HER2 testing is crucial for breast cancer treatment decisions. Standardizing methods like IHC and FISH improves reliability and patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Canadian Surgery Forum: Abstracts of presentations to the Annual Meetings of the Canadian Association of Bariatric Physicians and Surgeons, Canadian Association of General Surgeons, Canadian Association of Thoracic Surgeons, Canadian Hepato-Pancreato-Biliary Association, Canadian Society of Surgical Oncology, Canadian Society of Colon and Rectal Surgeons, Vancouver, BC, Sept. 17-21, 2013.

Canadian journal of surgery. Journal canadien de chirurgie·2025
Same author

Author Correction: A dense ring of the trans-Neptunian object Quaoar outside its Roche limit.

Nature·2024
Same author

A dense ring of the trans-Neptunian object Quaoar outside its Roche limit.

Nature·2023
Same author

Canadian Surgery Forum 2018: St. John's, NL Sept. 13-15, 2018.

Canadian journal of surgery. Journal canadien de chirurgie·2022
Same author

Canadian Surgery Forum: Abstracts of presentations to the Annual Meetings of the Canadian Association of Bariatric Physicians and Surgeons, Canadian Association of General Surgeons, Canadian Association of Thoracic Surgeons, Canadian Hepato-Pancreato-Biliary Society, Canadian Society of Surgical Oncology, Canadian Society of Colon and Rectal Surgeons, London, Ont. Sept. 15-18, 2011.

Canadian journal of surgery. Journal canadien de chirurgie·2022
Same author

2021 Canadian Surgery Forum: Virtual, online Sept. 21-24, 2021.

Canadian journal of surgery. Journal canadien de chirurgie·2022
Same journal

Real-World Outcomes in Acute Promyelocytic Leukemia: A 13-Year Cohort from Qatar.

Oncology·2026
Same journal

SF3A3 in Liver Hepatocellular Carcinoma: Oncogenic Role and Prognostic Significance.

Oncology·2026
Same journal

Letter to the Editor.

Oncology·2026
Same journal

FLAG-Based Versus Standard 7+3 Induction Therapy in Adults with Newly Diagnosed Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis.

Oncology·2026
Same journal

Longitudinal Changes in Body Weight and Body Mass Index in Patients with Chronic-Phase Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors: A Retrospective Observational Study.

Oncology·2026
Same journal

Rising lung cancer burden attributable to high fasting plasma glucose in women aged ≥50 years: age-, SDI-, and BRICS-specific patterns from GBD 1990-2021.

Oncology·2026
See all related articles

Area of Science:

  • Oncology
  • Molecular Pathology
  • Biomarker Validation

Background:

  • HER2 amplification/overexpression in breast cancer correlates with poor prognosis.
  • HER2 status influences treatment decisions, predicting response to HER2-targeted therapies like Herceptin.
  • HER2 testing is integral to routine breast cancer patient assessment globally.

Purpose of the Study:

  • To address the need for standardized and validated HER2 testing methodologies.
  • To evaluate the clinical utility and reproducibility of HER2 testing in breast cancer.
  • To establish reliable HER2 testing algorithms for clinical practice.

Main Methods:

  • Comparison of Immunohistochemistry (IHC) and Fluorescence In Situ Hybridization (FISH) for HER2 assessment.
  • Investigation of Polymerase Chain Reaction (PCR)-based HER2 testing approaches.

Related Experiment Videos

  • Development and application of a Canadian HER2 testing algorithm.

    • Main Results:

    • IHC and FISH demonstrate high concordance for HER2 testing.
    • PCR-based methods show promise for HER2 analysis.
    • A Canadian algorithm defines HER2-positive cases (>10% tumor cells with specific membrane staining via IHC) and recommends confirmatory FISH or quantitative PCR for indeterminate results.

    Conclusions:

    • Standardization and technical validation of HER2 testing are essential.
    • Current methods like IHC and FISH are valuable, with PCR emerging as a promising alternative.
    • Further research is needed to correlate HER2 testing results with clinical outcomes.